At LEO Pharma we recognize and respect the need to protect your asset – the compounds that could provide future collaboration and business opportunity. First, as a reminder, the aim of LEO Pharma Open Innovation is to generate scientific data in order to explore collaboration based on your compounds and our disease-relevant assays. At this point we do not ask for the Partner to give up any intellectual property.
The Open Innovation agreement will not affect any intellectual ownership - any intellectual property that the Partner have in the submitted compounds will remain with the Partner.
What is yours will remain yours.
The data and results generated by LEO Pharma Open Information is owned by the Partner.